Article | March 12, 2020

Changes To Research Made In Response To COVID-19

Source: WCG
Laboratory Services

WIRB-Copernicus IRB has received questions from several research sponsors about the appropriate process for making changes to clinical studies in response to the current COVID-19 epidemic. These changes may include things like:

  • Decreasing the number of protocol-mandated in-person study visits to healthcare facilities
  • Replacing protocol-mandated visits to healthcare facilities with home visits or telemedicine,
    allowing blood draws at remote or commercial laboratories
  • Shipping investigational products directly to research participants

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: